1-(6-Bromopyridin-3-yl)-2,2,2-trifluoroethanol, 95+%, 5g

5-(Trifluoromethyl)thiazol-2-amine hydrochloride, 97%, 1g

3-(2,4-Dimethylphenyl)-1,2-oxazol-5-amine, 95%, 5g

1,3-Dibromo-2-difluoromethoxy-benzene, 95+%, 1g

DL-Serine, min. 99%, for biochemistry, 500 g, plastic packaging.

Methyl 5-methyl-4-nitrothiophene-2-carboxylate, 96%, 1g

1-Bromo-4-chloro-3-fluoro-2-(methoxymethyl)benzene, 98%, 1g

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-acetyl-L-lysine>98.0%(HPLC)(T)5g

1,1'-(4,6-Dihydroxy-1,3-phenylene)-bis-ethanone, 99.0%, 5g

(3-Chloro-4-(difluoromethoxy)phenyl)methanol, 98%, 500mg

(9H-Fluoren-9-yl)methyl 3-hydroxypyrrolidine-1-carboxylate, 98%, 10g

4-Chloro-7-(triisopropylsilyl)-7H-pyrrolo[2,3-d]pyrimidine, 98%, 250mg

1-Oxa-6-azaspiro[3.5]nonane, 95.0%, 100mg